Authors:
MCVEY M
SMITS GJ
COX BF
PERRONE MH
CLARK KL
Citation: M. Mcvey et al., CARDIOPROTECTIVE EFFECTS OF THE NOVEL ADENOSINE A(1) A(2) RECEPTOR AGONIST, AMP-579/, The FASEB journal, 12(4), 1998, pp. 452-452
Authors:
HAN SP
YANG CL
CHEN XL
NAES L
COX BF
WESTFALL T
Citation: Sp. Han et al., DIRECT EVIDENCE FOR THE ROLE OF NEUROPEPTIDE-Y IN SYMPATHETIC-NERVE STIMULATION-INDUCED VASOCONSTRICTION, American journal of physiology. Heart and circulatory physiology, 43(1), 1998, pp. 290-294
Authors:
SMITS GJ
MCVEY M
COX BF
PERRONE MH
CLARK KL
Citation: Gj. Smits et al., CARDIOPROTECTIVE EFFECTS OF THE NOVEL ADENOSINE-A(1) ADENOSINE-A(2) RECEPTOR AGONIST AMP-579 IN A PORCINE MODEL OF MYOCARDIAL-INFARCTION, The Journal of pharmacology and experimental therapeutics, 286(2), 1998, pp. 611-618
Authors:
BURKE SE
NELSON RA
LUBBERS NL
WEGNER CD
OPGENORTH TJ
COX BF
Citation: Se. Burke et al., SELECTIVITY OF ABT-627, AN ANTAGONIST OF THE ENDOTHELIN-A (ET-A) RECEPTOR, ON PRESSOR-RESPONSES IN THE DOMESTIC PIG, The FASEB journal, 11(3), 1997, pp. 2904-2904
Authors:
COX BF
CLARK KL
PERRONE MH
WELZEL GE
GREENLAND BD
COLUSSI DJ
MERKEL LA
Citation: Bf. Cox et al., CARDIOVASCULAR AND METABOLIC EFFECTS OF ADENOSINE A(1)-RECEPTOR AGONISTS IN STREPTOZOTOCIN-TREATED RATS, Journal of cardiovascular pharmacology, 29(3), 1997, pp. 417-426
Citation: Gj. Smits et al., REGIONAL HEMODYNAMIC DOSE-RESPONSE OF LEMAKALIM AND GLYBENCLAMIDE IN ANESTHETIZED RATS, Journal of cardiovascular pharmacology, 29(1), 1997, pp. 49-56
Authors:
COX BF
CLARK KL
WELZEL GE
GREENLAND BD
ROACH AG
VALERIO MG
STANKUS GP
PERRONE MH
Citation: Bf. Cox et al., MECHANISMS INVOLVED IN VENTRICULAR HYPERTROPHY - ROLE OF P2X, P2Y, AND ENDOTHELIN RECEPTORS, The FASEB journal, 10(3), 1996, pp. 1784-1784
Citation: Gj. Smits et Bf. Cox, REGIONAL HEMODYNAMIC-EFFECTS OF PURINERGIC P2 RECEPTOR SUBTYPE AGONISTS IN RATS, The FASEB journal, 10(3), 1996, pp. 3422-3422
Citation: Bf. Cox et Gj. Smits, REGIONAL HEMODYNAMIC-EFFECTS OF PURINERGIC P2 RECEPTOR SUBTYPE AGONISTS IN RATS, The Journal of pharmacology and experimental therapeutics, 277(3), 1996, pp. 1492-1500
Authors:
BISHOP VS
RYUZAKI M
CAI Y
NISHIDA Y
COX BF
Citation: Vs. Bishop et al., ANGIOTENSIN II-DEPENDENT HYPERTENSION AND THE ARTERIAL BAROREFLEX, Clinical and experimental hypertension, 17(1-2), 1995, pp. 29-38
Citation: Bf. Cox et al., EFFECTS OF THE A1 SELECTIVE AGONIST GR79236 AND THE A1 A3 AGONIST APNEA ON MYOCARDIAL-FUNCTION AND HEMODYNAMICS IN THE DOG/, The FASEB journal, 9(3), 1995, pp. 121-121
Citation: Bd. Greenland et al., CARDIOVASCULAR AND ANTILIPOLYTIC EFFECTS OF A1 SELECTIVE ADENOSINE AGONISTS IN TELEMETRY INSTRUMENTED DIABETIC RATS, The FASEB journal, 9(3), 1995, pp. 121-121
Citation: Bf. Cox et al., ISCHEMIA-REPERFUSION SELECTIVELY ATTENUATES CORONARY VASODILATATION TO AN ADENOSINE A(2)-AGONIST BUT NOT TO AN A(1)-AGONIST IN THE DOG, British Journal of Pharmacology, 111(4), 1994, pp. 1233-1239
Authors:
MERKEL LA
RIVERA LM
COLUSSI DJ
PERRONE MH
SMITS GJ
COX BF
Citation: La. Merkel et al., INVITRO AND INVIVO CHARACTERIZATION OF AN A1-SELECTIVE ADENOSINE AGONIST, RG14202, The Journal of pharmacology and experimental therapeutics, 265(2), 1993, pp. 699-706